Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks

Lignende værker

• Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes
  af: Kashiwagi, Atsunori, et al.
  Udgivet: (2011)
• Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes
  af: Tajima, Naoko, et al.
  Udgivet: (2013)
• Safety and efficacy of addition of sitagliptin to rapid-acting insulin secretagogues for glycemic control, including post-prandial hyperglycemia, among Japanese with type 2 diabetes mellitus
  af: Tajima, Naoko, et al.
  Udgivet: (2015)
• Long-term treatment study of global standard dose metformin in Japanese patients with type 2 diabetes mellitus
  af: Odawara, Masato, et al.
  Udgivet: (2017)
• Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week randomized trial
  af: Schernthaner, Guntram, et al.
  Udgivet: (2013)